T3 DENTAL IMPLANT

K122300 · Biomet 3i · DZE · Jan 30, 2013 · Dental

Device Facts

• Record ID: K122300
• Device Name: T3 DENTAL IMPLANT
• Applicant: Biomet 3i
• Product Code: DZE · Dental
• Decision Date: Jan 30, 2013
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 872.3640
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

BIOMET 3i Dental implants are intended for surgical placement in the upper or lower jaw to provide a means for prosthetic attachment in single tooth restorations and in partially or fully edentulous spans with multiple single teeth, or as a terminal or intermediary abutment for fixed or removable bridgework, and to retain overdentures.

Device Story

3i T3 Dental Implants are endosseous root-form implants manufactured from Commercially Pure Grade 4 titanium. They feature a screw-type design with straight-wall or tapered bodies, available with standard or Prevail platform collars. The apical portion features a roughened surface (grit-blasted and acid-etched, with optional nano-scale discrete crystalline deposition of calcium phosphate), while the coronal portion retains the OSSEOTITE surface. Implants are surgically placed by clinicians in the upper or lower jaw to provide prosthetic attachment for single or multiple tooth restorations, bridgework, or overdentures. The device provides primary stability to restore chewing function. The system includes internal connection/anti-rotation features (dual hex or six-point hex). Clinical benefit is derived from the integration of the implant into the jawbone to support dental prosthetics.

Clinical Evidence

No new clinical testing was conducted. The manufacturer provided postmarket clinical data on over 6,829 implants placed between 1996 and 2011 to support the safety and performance of the implant design, demonstrating clinical survival rates across various diameters. No implant fractures were reported as an etiology for failure.

Technological Characteristics

Material: CP4 Titanium (ASTM F67). Surface: Grit-blasted, acid-etched, optional DCD CaP. Design: Straight-wall or tapered screw-type. Connection: Internal (dual hex/six-point hex). Dimensions: 3.25-6mm diameter, 8.5-18mm length. Sterilization: Sterile. Connectivity: N/A. Software: None.

Indications for Use

Indicated for surgical placement in upper or lower jaw for prosthetic attachment in single tooth restorations, partially or fully edentulous spans, fixed or removable bridgework, and overdenture retention.

Regulatory Classification

Identification

An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.

Special Controls

*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.

Predicate Devices

• OSSEOTITE 2 Certain Implants (K100724)
• Certain Implants (K063341)
• NanoTite Implants (K051461)
• ITI Dental Implant System (K003271)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the text "BIOMET 3i" in a stylized, bold font. The letters are outlined, giving them a three-dimensional appearance. The "3i" portion of the text is smaller and has a trademark symbol next to it.

K 1.22300

## JAN 3 0 2013

## 510(k) SUMMARY

A summary of 510(k) safety and effectiveness information in accordance with the requirements of 21 CFR 807.92

| Submitter Information | |
|------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Name | BIOMET <i>3i</i> |
| Address | 4555 Riverside Drive<br>Palm Beach Gardens, Florida 33410 |
| Phone number | [phone] |
| Fax number | [phone] |
| Establishment<br>Registration Number | 1038806 |
| Name of contact<br>person | Jacquelyn Hughes |
| Date prepared | January 17, 2012 |
| Name of device | |
| Trade or proprietary<br>name | <i>3i</i> T3 Dental Implant |
| Common or usual<br>name | Endosseous Dental Implants |
| Classification name | Implant, Endosseous, Root-Form |
| Classification panel | Dental |
| Regulation | 21CFR §872.3640 |
| Product Code(s) | DZE |
| Legally marketed<br>device(s) to which<br>equivalence is claimed | K100724 OSSEOTITE® 2 Certain Implants<br>K063341 Certain® Implants<br>K051461 NanoTite® Implants<br>K00321 ITI Dental Implant System |
| Reason for 510(k)<br>submission | Addition to BIOMET <i>3i</i> dental implant product line to include<br>an implant with a multi-level surface topography by adding a<br>Calcium Phosphate (CaP) media-blasted roughened surface<br>on the apical aspect of existing BIOMET <i>3i</i> Certain internal<br>connection OSSEOTITE 2 (K100724) and internal<br>connection Tapered (K063341) product lines. |
| Device description | The <i>3i</i> T3 Dental Implants are manufactured from<br>Commercially Pure Grade 4 titanium and feature a<br>roughened apex and traditional OSSEOTITE® coronal<br>surface. The dental implants will consist of a straight wall<br>or tapered body type with a basic screw-type design in<br>various platform options and feature an internal<br>connection/anti-rotation feature; 3.25 and 4/3mm has a<br>12pt dual hex; 4, 5, 6, 5/4 & 6/5mm has a six-point hex at<br>the top and lower 12-point dual hex. The <i>3i</i> T3 Dental<br>Implants are available with either the Prevail platform |
| Intended use of the device | switching feature or standard collar. In addition, the implants are offered with and without the nano-scale discrete crystalline deposition (DCD) calcium phosphate (CaP) surface treatment. |
| | The 3/T3 Dental Implants are intended for immediate function on single tooth and/or multiple tooth applications when good primary stability is achieved, with appropriate occlusal loading, in order to restore chewing function. |
| Indications for use | BIOMET dental implants are intended for surgical placement in the upper or lower jaw to provide a means for prosthetic attachment in single tooth restorations and in partially or fully edentulous spans with multiple single teeth utilizing delayed or immediate loading, or with a terminal or intermediary abutment for fixed or removable bridgework, and to retain overdentures. |

4555 Riverside Drive
Palm Beach Gardens, FL 33410 Office: 561.776.6700 Fax: [phone]
www.3i -online.com

{1}------------------------------------------------

Image /page/1/Picture/0 description: The image shows the logo for BIOMET 3i. The logo is in black and white and features a stylized font. The "i" in "3i" has a small box above it with the letters "TM" inside.

Summary of the technological characteristics of the device compared to the predicate

| Characteristic | New Device | K100724 | K063341 | K051461 | K003271 |
|------------------|---------------|---------------|---------------|---------------|-------------|
| Description | 3i T3 Dental | Osseotite 2 | Certain | Nanotite | Dental |
| | Implants | Dental | Implants | Implants | Implant |
| | | Implants | | | System |
| Material | CP4 Titanium | CP4 Titanium | CP Titanium | CP Titanium | CP4 |
| | (ASTM F67) | (ASTM F67) | (ASTM F) | (ASTM F67) | Titanium |
| | | | Ti -6AL-4V | Ti -6AL-4V | (ASTM F67) |
| | | | (ASTM F136) | (ASTM F136) | |
| Surface | Grit Blast | Acid-etch | Acid-etch | Acid-etch | Grit Blast |
| Finish | Acid-etch | | | DCD | Acid-etch |
| | DCD | | | | |
| Implant | Straight-Wall | Straight-wall | Straight-Wall | Straight-Wall | Solid self- |
| Design | Tapered | | Tapered | Tapered | tapping |
| | | | | | |
| Collar Design | Standard | Standard | Standard | Standard | Unknown |
| | Prevail | | Prevail | Prevail | |
| Diameter | Standard: | Standard: | Standard: | Standard: | various |
| | 3.25- 6mm | 3.25- 6mm | 3.25- 6mm | 3.25- 6mm | |
| | Prevail: | | Prevail: | Prevail: | |
| | 4/3-6/5mm | | 4/3-6/5mm | 4/3-6/5mm | |
| Length | 8.5-18mm | 8.5-18mm | 7-20mm | 8.5-20mm | various |
| Connection | Internal | Internal | Internal | Internal | External |
| Labeling | Sterile | Sterile | Sterile | Sterile | Sterile |
| | | | | | |
| PERFORMANCE DATA | | | | | |

4555 Riverside Drive
Palm Beach Gardens, FL 33410
Office: 561.7776.6700
Fax: [phone]
www.3i -online.com

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for BIOMET 3i. The logo is in black and white and features a stylized font. The "3i" portion of the logo is smaller and to the right of the word "BIOMET".

| SUMMARY OF NON-CLINICAL TESTS CONDUCTED FOR DETERMINATION OF | | | | | | |
|-------------------------------------------------------------------------------------------|----------------------------|------|----------------------------|------------------------------|--|--|
| SUBSTANTIAL EQUIVALENCE | | | | | | |
| Performance Test Summary-New Device | | | | | | |
| Characteristic | Standard/Test/FDA Guidance | | | Results Summary | | |
| 3/T3 & 3/T3 with DCD | ISO 14801:2007 | | Cyclic Fatigue testing met | | | |
| Implants - Cyclic Fatigue | | | indications | | | |
| Testing | | | | | | |
| 3/T3 & 3/T3 with DCD | Biomet 3i procedure | | Comparison of the original | | | |
| Implants - Print Verification | | | | and design verification test | | |
| | | | | models confirms the prints | | |
| | | | | convey the design intent. | | |
| Comparative Performance Information Summary | | | | | | |
| Characteristic | Requirement | | New Device | Predicate Device | | |
| 31 T3 vs. 31T3 with DCD | Meet or exceed | Meet | | K100724 | | |
| Implants - Cyclic Fatigue | parameters | | | | | |
| Testing | | | | | | |
| 3/T3 with DCD Nano-Scale | Meet or exceed | | Exceed | K051461 | | |
| Calcium Phosphate | parameters | | | | | |
| Adhesion Strength | | | | | | |
| Tolerance Analysis 3iT3 & | Meet or exceed | | Meet | K100724 | | |
| 3/T3 with DCD Implants - | parameters | | | | | |
| Tolerance Analysis | | | | | | |
| 3/T3 and 3/T3 with DCD | Meet or exceed | | Meet | K100724 | | |
| Implants - Torque Testing | parameters | | | | | |
| 3iT3 & 3iT3 with DCD | Meet or exceed | | Meet | K100724 | | |
| Implants - Fit Check/ | parameters | | | | | |
| Mating Analysis | | | | | | |
| SUMMARY OF CLINICAL TESTS CONDUCTED FOR DETERMINATION OF | | | | | | |
| SUBSTANTIAL EQUIVALENCE AND/OR OF CLINICAL INFORMATION | | | | | | |
| Clinical Performance Data/Information: Data was provided from postmarket clinical studies | | | | | | |
| of the prodicato implants cronented or cunnorted by Biomet 22. Data on over 6. 200 | | | | | | |

sponsored or supported by Biomet 31. Data on over 6,829 implants placed in the posterior from 1996 -2011 were available to demonstrate the difference in clinical survival rates for the various diameters of implants. None of the implant cases included fracture as an etiology for implant failure.

CONCLUSIONS DRAWN FROM NON-CLINICAL AND CLINICAL DATA

No additional clinical testing was necessary for a determination of substantial equivalence.

The results of mechanical testing indicated the devices performed within the intended use, did not raise any new safety and efficacy issues and were found to be substantially equivalent to the predicate devices.

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular fashion around the symbol. The logo is black and white.

## DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

January 30, 2013

Ms. Jacquelyn A. Hughes, RAC Director, Regulatory Affairs & Clinical Research Biomet 31 4555 Riverside Drive PALM BEACH GARDENS FL 33410

Re: K122300

i

Trade/Device Name: 3i T3TM Dental Implants Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: II Product Code: DZE Dated: January 9, 2013

Received: January 14, 2013

Dear Ms. Hughes:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices. good manufacturing practice. labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{4}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours.

Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

## Indications for Use

K122300 510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________

Device Name: 3i T3™ Dental Implants

Indications For Use:

BIOMET 3/ Dental implants are intended for surgical placement in the upper or lower jaw to provide a means for prosthetic attachment in single tooth restorations and in partially or fully edentulous spans with multiple single teeth, or as a terminal or intermediary abutment for fixed or removable bridgework, and to retain overdentures.

Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use NO (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 1 of 1

| Susan Runner DDS, MA | 2013.01.24 |
|----------------------|------------------|
| | 15:26:11 -05'00' |

(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices

510(k) Number: